СПИСОК ЛИТЕРАТУРЫ
1. Авдеев, С.Н. Пневмония и острый респираторный дистресс- синдром, вызванные вирусом гриппа А/НШ1 [Текст] / С.Н. Авдеев // Пульмонология. - 2010. - Прил. «Грипп A/H1N1: уроки пандемии».
- С. 32-46.2. Авдеев, С.Н. Тяжелые формы пандемического гриппа A/H1N1 2009 [Текст] / С.Н. Авдеев // Атмосфера. Пульмонология и аллергология. - 2010. - № 4. - С. 1-10.
3. Алексеев, А.М. Интенсивная терапия больных с тяжелым течением гриппа А(НШ1), осложненного пневмонией [Текст] /
А.М. Алексеев, О.В. Шупинский, К.Н. Храпов // Вестник анестезиологии и реаниматологии. - 2009. - Т.6, № 6. - С. 35-39.
4. Андрейчиков, А.В. Детерминированность метаболического иммунодефицита при аномалиях положения почек: дис. ... д-ра мед. наук: 14.00.16 [Текст] / Андрейчиков Александр Владимирович. - Томск, 2003. - 202 с.
5. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике [Текст] / Под ред. А.Г. Чучалина [и др.]. - М.: Атмосфера, 2014. - 45 с.
6. Грипп: эпидемиология, диагностика, лечение, профилактика [Текст] / Под редакцией акад. РАМН проф. О.И. Киселева, д-ра мед. наук Л.М. Цыбаловой, акад. РАМН проф. В.И. Покровского. - М.: ООО «Издательство «Медицинское информационное агентство», 2012. - 496 с.
7. Запольских, А.М. Особенности эпидемиологии и профилактики пандемического гриппа в условиях мегаполиса: дис. ... канд. мед наук: 14.02.02 [Текст] / Запольских Анна Михайловна. - Москва, 2014. - 213 с.
8. Зарубаев, В.В. Использование индукторов апоптоза в терапии экспериментальной гриппозной инфекции и предотвращение хронических постгриппозных поражений легких [Текст] / В.В. Зарубаев // Цитология. - 2014. - Т. 56, № 3. - С. 241-247.
9. Использование прогностических математических моделей для выявления больных туберкулезом легких [Текст] / А.Н. Наркевич,
К.А. Виноградов, Н.М. Корецкая, А.А. Наркевич // Туберкулез и болезни легких.
- 2014. - Т. 91, № 9. - С. 44-45.10. Методические рекомендации по диагностике и лечению гриппа, утвержденные Министерством здравоохранения РФ. - Москва, М.: Издательство. - 2016. - 29 с.
11. Организация медицинской помощи при внебольнич- ных пневмониях, связанных с эпидемическим подъемом заболеваемости гриппом и ОРВИ: метод. рекомендации для врачей / И.П. Артюхов, И.В. Демко, Е.Е. Корчагин [и др.]; под.ред. А.Г. Чучалина. М-во здравоохранения Краснояр. края, ФГБОУ ВО КрасГМУ им. проф. В.Ф. Войно-Ясенецкого Минздрава России. - М., 2016. - 108 с.
12. Особенности современного гриппа [Текст] / Н.А. Малышев, М.В. Базарова, Г.Н. Кареткина [и др.] // Туберкулез и социальнозначимые забоевания. - 2014. - № 4. - С. 43-51.
13. Показатели воспалительных реакций, гемостаза и эндотели- оза при тяжелой пневмонии в зависимости от исходов заболевания и их сопряжение [Текст] / А.П. Момот, И.В. Балацкая, Т.И. Мартыненко и др. // Современные проблемы науки и образования. - 2014. - № 2. - С. 344.
14. Пульмонология: национальное руководство [Текст] / под ред. А.Г. Чучалина. - М.: ГЭОТАР-Медиа, 2014. - 800 с.
15. Романова, Е.Н. Пневмонии у больных гриппом А/НШ1/09: клинико-патогенетические закономерности и исходы: дис. ... д-ра мед. наук: 14.00.05 [Текст] / Романова Елена Николаевна. - Чита, 2014. - 314 с.
16. Савченко, А.А. Высокочувствительное определение активности дегидрогеназ в лимфоцитах периферической крови человека био- люминесцентным методом [Текст] / А.А. Савченко, Л.Н. Сунцова // Лаб. дело. - 1989. - № 11. - С. 23-25.
17. Савченко, А.А. Метаболические особенности лимфоцитов крови у людей с нарушениями иммунореактивности, проживающих в разных климато-географических условиях: Автореф. дис. ... д-ра мед. наук [Текст] / А.А. Савченко. - Томск, 1996. - 30 с.
18. Савченко, А.А. Основы клинической иммунометаболоми- ки [Текст] / А.А. Савченко, А.Г. Борисов. - Новосибирск: Наука,
2012. - 263 с.
19. Савченко, А.А. Содержание АТФ и активность НАД(Ф)- зависимых дегидрогеназ в лимфоцитах при иммунодефицитассо- циированных заболеваниях у пришлых жителей Эвенкии [Текст] /
A.
А. Савченко, С.В. Смирнова, А.Г. Борисов // Бюлл. СО РАМН. - 2010. - Т. 30, № 3. - С. 33-38.20. Симаненков, В.И. Внебольничная пневмония [Текст] / В.И. Си- маненков, Е.А. Лутаенко // Лечащий врач. - 2014. - № 11. - С. 112-114.
21. Федеральные клинические рекомендации Российского респираторного общества по диагностике и лечению тяжелых форм гриппа [Текст] / А.Г. Чучалин, С.Н. Авдеев, А.Л. Черняев [и др.] // Пульмонология. - 2014. - № 5. - С. 11-19.
22. Фесенко, О.В. Тяжелая внебольничная пневмония и шкалы оценки прогноза [Текст] / О.В. Фесенко, А.И. Синопальников // Практическая пульмонология. - 2014. - № 2. - С. 56-59.
23. Харитонов, М.А. Пневмонии [Текст] / М.А. Харитонов,
B. А. Андреев, Т.И. Оболенская // Медицинская лабораторная диагностика: программы и алгоритмы. - М.: ГОЭТАР-Медиа, 2014. - Гл. 15. - С. 430-458.
24. Чаванина, С.А. Клинико-патогенетические закономерности течения внебольничных пневмоний в период эпидемии гриппа А А/ H1N1/09 у детей: дис. ... канд. мед. наук: 14.01.08 [Текст] / Чаванина Светлана Александровна. - Хабаровск, 2014. - 142 с.
25. Чучалин, А.Г. Клинические рекомендации по диагностике, лечению и профилактике тяжелой внебольничной пневмонии у взрослых [Электронный ресурс] / А.Г. Чучалин // Российское респираторное общество. - 2014. - Режим доступа: http://www.pulmonology. ru/publications/guide.php.
26. Чучалин А.Г. Пневмония: актуальная проблема медицины XXI века [Текст] / А.Г. Чучалин // Пульмонология. - 2015. - Т. 25, № 2. - С. 133-142.
27. Чучалин, А.Г. Пневмония: актуальная проблема медицины XXI века [Текст] / А.Г. Чучалин // Терапевтич. архив. - 2016. - Т. 88, № 3. - С. 4-12.
28. Эпидемический сезон 2013-2014 гг. Госпитальный мониторинг и противовирусная терапия гриппа [Текст] / Л.В. Колобухина,
Е.И. Бурцева, М.Ю. Щелканов [и др.] // Терапевтический архив. - 2014. - Т. 86, № 10. - С. 52-59.
29. A case of severe ARDS caused by novel swine-origin influenza (A∕H1N1pdm) virus: a successful treatment with direct hemoperfusion with polymyxin В-immobilized fiber [Text] ∕ T Yokoyama [et al.] ∕∕
J.
Clin. Apher. - 2010. - Vol. 25 (6). - Р 350-353.30. A Complicated Message: Identification of a Novel PB 1-Related Protein Translated from Influenza A Virus Segment 2 mRNA [Text] ∕ H.M. Wise, A. Foeglein, J. Sun [et al.] ∕∕ J. Virol. - 2009. - Vol. 83, № 16. - P. 8021-8031.
31. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A(H1N1) [Text] ∕ J.K. Louie, M. Acosta, M.C. Samuel [et al.] ∕∕ Clin. Infect. Dis. - 2011. - Vol. 52, N 3. - P. 301-312.
32. Adeola, O.A. Detection of pandemic strain of influenza virus (A∕H1N1∕pdm09) in pigs, West Africa: implications and considerations for prevention of future influenza pandemics at the source [Электронный ресурс] ∕ O.A. Adeola, B.O. Olugasa, B.O. Emikpe ∕∕ Infect Ecol Epidemiol. - 2015. - 5: 30227. - Режим доступа: httpι∕∕dx.doi.org∕10.3402∕ iee.v5.30227.
33. Agarwal, P.P. Chest radiographic and CT finings in novel swineorigin influenza A (HlNl) virus [Text] ∕ PP Agarwal, S. Sinti, E.A. Kaze- rooni ∕∕ Am. J. Roentgenol. - 2009. - P. 1488-1493.
34. Allen, S.J. Chemokine: receptorstructure, interactions, andantag- onism [Text] ∕ SJ. Allen, S.E. Crown, TM. Handel ∕∕ Annu Rev Immunol. - 2007. - Vol. 25. - Р. 787-820.
35. Almansa, R. Immunopathogenesis of 2009 pandemic influenza [Text] ∕ R. Almansa, J.F Bermejo-Martin, R.O. De Lejarazu Leonardo ∕∕ Enferm. Infecc. Microbiol. Clin. - 2012. - Vol. 30, Suppl. 4. - P. 18-24.
36. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1)2009 influenza virus ∕ Y. Liu et al. ∕∕ Journal of Virology. 2010. - V.84, № 22. - P. 12069-12074.
37. An under-recognized influenza epidemic identified by rapid in- fiuenza testing, Southern Spi Lanka, 2013 [Text] ∕ L.G. Tillekeratne, T Qstybe, C.K. [et al.] ∕∕ Bodinayake American Journal of Tropical Medicine and Hygiene. - 2015. - Т 92, № 5. - P. 1023-1029.
38. Bedford, T. Global circulation patterns of seasonal influenza viruses vary with antigenic drift [Text] ∕ T. Bedford, S. Riley, I.G. Barr ∕∕ Nature. - 2015. - 523 (7559). - P. 217-220.
39. Benes, J. Scoring systems to evaluate prognosis of community-acquired pneumonias [Text] / J. Benes, O. Dzupova, Z. Blechova [et al.] // Vnitr. Lek. - 2012. - Vol. 58, № 5. - P. 357-364.
40. Blood biomarkers for personalized treatment and patient management decisions in community-acquired pneumonia [Text] / P. Schuetz,
A. Litke, W.C. Albrich [et al.] // Curr. Opin. Infect. Dis. - 2013. - Vol. 26, № 2. - P. 159-167.
41. Boyum, A. Separation of leukocytes from blood and bone marrow [Text] / A. Boyum // Scand. J. Clin. Lab. Invest. - 1968. - Vol. 21, № 1. - P. 90-109.
42. Brockwell-Staats C. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A(H1N1) [Text] /
C. Brockwell-Staats, R.G. Webster, RJ. Webby // Influenza Respir. Vir. - 2009. - Vol. 3. - P. 207-213.
43. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses [Text] / K. Scheible [et al.] // Vaccine. - 2011. - Vol. 29 (11). - P. 2159-2168.
44. CDC, 2009. Novel Influenza A (H1N1) Virus Infections in Three Pregnant Women - United States, April-May 2009. Centers for Disease Control and Prevention (US) [Text] // MMWR. Morbidity and mortality weekly report. 2009: 58 (18). P. 497-500. Situation Update, 8 January 2014.
45. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study [Text] / D.M. Musher, I.L. Roig, G. Cazares [et al.] // J. Infect. - 2013. - Vol. 67. - P. 11-18.
46. Cellular immune correlates of protection against symptomatic pandemic influenza [Text] / S. Sridhar [et al.] // Nature Medicine. -
2013. - Vol. 19. - P. 1305-1312.
47. Chakrabarti, A.K. An insight into the PB1F2 protein and its multifunctional role in enhancing the pathogenicity of the influenza A viruses [Text] / A.K. Chakrabarti, G. Pasricha // J. Virol. - 2013. - Vol. 440 (2). - P. 97-104.
48. Characterization of an enhanced antigenic change in the pandemic 2009 H1N1 influenza virus haemagglutinin [Text] /
B. Garcia-Barreno [et al.] // J. Gen. Virol. - 2014. -Vol. 95. - P. 1033-1042.
49. Characterization of the human CD8+ T cell response following infection with 2009 pandemic influenza H1N1 virus [Text] / M.L. Hillaire [et al.] // J. Virol. - 2011. - Vol. 85 (22). - P. 12057-12061.
50. Chen, J. The immunobiology of SARS [Text] / J. Chen, K. Sub- barao // Annu RevImmunol. - 2007. - Vol.25. - Р 443-472.
51. Ohoby, B. A. Respiratory infections: community-acquired pneumonia [Text] / B.A. Choby, P. Hunter // F.P. Essent. - 2015. - Vol. 429. - P. 11-21.
52. Clinical and Epidemiologic Characteristics of Hospitalized Patients with 2009 H1N1 Influenza Infection [Text] / S. Nayman Al- pat, G. Usluer, I. Ozgunes [et al.] // Influenza Res Treat. - 2012. - Vol. 23. - P. 1-5.
53. Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection [Text] / H. Tse [et al.] // PLoS ONE. - 2011. - Vol. 6 - P. e22534.
54. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection [Text] / N. Hagau [et al.] // Crit. Care Med. - 2010. - Vol. 14 (6). - P. 203.
55. Clinical aspects of pandemic 2009 influenza A/H1N1/ virus infection [Text] / E. Bautista [et al.] // N. Engl. J. Med. - 2010. - Vol. 362. - Р 1708-1719.
56. Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009 [Text] / N. Komiya, Y. Gu, H. Kamiya [et al.] // Euro Surveill. - 2009. - Vol. 14, № 29. - P. 19272.
57. Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcome [Text] / J.L. Clarke, T.I. Vulliamy, D. Roper [et al.] // Blood Cells Mol. Dis. - 2003. - Vol. 30, № 3. - P. 258-263.
58. Community-acquired pneumonia due to pandemic A (H1N1)2009 influenza virus methicillin resistant staphylococcus aureus co-infection [Text] / RJ. Murray [et al.] // PLoS ONE. - 2010. - Vol. 5(1). - P. 8705.
59. Community-acquired pneumonia during the first post-pandemic influenza season: a prospective, multicentre cohort study [Text] / D. Vi- asus, C. Marinescu, A. Villoslada [et al.] // J. Infect. - 2013. - Vol. 67, № 3. - P. 185-193.
60. Complex formation between malate dehydrogenase and isocitrate dehydrogenase from Bacillus subtilis is regulated by tricarboxylic
acid cycle metabolites [Text] ∕ M. Bartholomae, F.M. Meyer, F.M. Com- michau [et al.] ∕∕ FEBS J. - 2014. - № 281(4). - Р. 1132-1143.
61. Control of coronavirus infection through plasmacytoid dendriticcell-derived type I interferon [Text] ∕ L. Cervantes-Barragan, R. Zust,
F. Weber [et al.] ∕∕ Blood. - 2007. - Vol. 109, № 3. - Р. 1131-1137.
62. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses [Text] ∕ S. Gras [et al.] ∕∕ PNAS. - 2010. - Vol. 107 (28). - P. 12599-12604.
63. Cunha, B.A. Swine influenza (H1N1) pneumonia: clinical considerations [Text] ∕ B.A. Cunha ∕∕ Infect Dis. Clin. N. Am. - 2010. - № 24. - P. 203-228.
64. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis [Text] ∕ Gao R. [et al.] ∕∕ Am. J. Pathol. - 2013. - Vol. 183. - P. 1258-1268.
65. DeBerardinis, R.J. Cellular metabolism and disease: what do metabolic outliers teach us? [Text] ∕ RJ. DeBerardinis, C.B. Thompson ∕∕ Cell. - 2012. - Vol. 148, № 6. - P. 1132-1144.
66. De Soli, P. Whole blood chemiluminescence: a new technical approach to assess oxygen-dependent microbial activity of granulocytes [Text] ∕ P. De Soli, S. Lippa, G. Lixxarru ∕∕ J. Clin. Lab. Autom. - 1983. - Vol. 3. - P. 391-400.
67. Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection [Text] ∕ Xichao Guo, Yu Chen, Xuefen Li, Haishen Kong [et al.] ∕∕ J. Virol. - 2011. - Vol. 8. - P. 1-6.
68. ECDC. Influenza in Europe. Season 2015-2016. [Электронный ресурс]. Режим доступа: httpι∕∕ecdc.europa.eu∕en∕healthtopics∕sea- sonal-influenza∕PublishingImages∕inflιienza-end-of-season-2015-16.jpg.
69. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults [Text] ∕ D.I. Bernstein, K.M. Edwards, C.L. Dekker [et al.] ∕∕ J. Infect Dis. - 2008. - Vol. 197, № 5. - P. 667-675.
70. Emergence of a novel swine-origin influenza A (H1N1) virus in humans [Text] ∕ Novel swine-origin influenza A (H1N1) virus investigation team; ES. Dawood, S. Jain, L. Finelli [et al.] ∕∕ N Engl J Med. - 2009. -Vol. 360, № 25. - P. 2605-2615.
71. Enhanced epidemiological surveillance of influenza A (H1N1)v in Italy [Text] / C. Rizzo, S. Declich, A. Bella [et al.] // Euro Surveill. - 2009. - Vol.14, № 27. - P. 19266.
72. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection [Text] / J.R. Teijaro [et al.] // Cell. - 2011. - Vol. 146. - P. 980-991.
73. Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis byrespiratory syncytial virus [Text] / A.E. Alvarez, F.A. Marson, C.S. Bertuzzo [et al.] // J. Pediatr. (Rio J). - 2013. - Vol. 89(6). - P. 531-543.
74. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza [Text] / M.L. Metersky, R.G. Masterson, H. Lode [et al.] // Int. J. Infect. Dis. - 2012. - Vol. 16. - P. 321-331.
75. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009 [Text] / L. Vaillant [et al.] // Eurosurveillance. - 2009. - Vol. 14 (33). - P. 1-6.
76. Epidemiology of influenza A (H1N1)v virus infection in Japan, May - June 2009 [Text] / T Shimada, Y. Gu, H. Kamiya [et al.] // Euro Surveill. - 2009. - Vol. 14, № 24. - P. 19244.
77. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany [Text] / M. Wedde, B. Biere, T Wolff [et al.] // Int J Med Microbiol. - 2015. - T. 305, № 7. - C. 762-75.
78. European Centre for Disease Prevention and Control and the World Health organization Regional Office for Europe [Electronic resource]. - Mode of access: http://www.pitt.edu/- super 1/lecture/ lec34601/036/htm. (15.04.2012).
79. European Centre for Disease Prevention and Control, Surveillance Report, January 8,2010,/ (Электронный ресурс) - Режим доступа: URL: http://ecdc.europa.eu/en/activities/ surveillance/EISN- Newsletter/100108_EISN.
80. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California [Text] / J. Louie [et al.] // JAMA. - 2009. - Vol. 302. - P. 1896-1902.
81. Factors associated with early hospital discharge of adult influenza patients [Text] / N. Lee, P.K. Chan, K.W Choi [et al.] // Antivir Ther. - 2007. - Vol. 12, № 4. - P. 501-508.
82. Fraser, Pandemic potential of a strain of influenza A(H1N1): early findings [Text] / Fraser C., Donnelly C.A., Cauchemez S. et al. // Science. - 2009. - Vol. 324. - P. 1557-1561.
83. Francis, T.J. A serological recapitulation of human infection with different strains of influenza virus [Text] / Francis TJ., Davenport F.M., Hennessy A.V. // Trans. Assoc. Am. Phys. 1953, 66: 231-239.
84. Frequency of D222G haemagglutinin mutant of pandemic (H1N1) pdm09 influenza virus in Tunisia between 2009 and 2011 [Text] / A.E. Moussi [et al.] // Diagnostic Pathology. - 2013. - Vol. 8 (124). - P. 1-5.
85. Frieman, M. SARS coronavirus and innate immunity [Text] / M. Frieman, M. Heise, R. Baric // Virus Res. - 2008. - Vol. 133, № 1. - Р. 101-112.
86. Fujihashi, K. Mucosal immunosenescence: new developments and vaccines to control infectious diseases [Text] / K. Fujihashi, H. Ki- yono // Trends in immnology. - 2009. - Vol. 30, № 7. - P. 334-343.
87. Functional polymorphisms of interferon-gamma affect pneumonia-induced sepsis [Text] / D. Wang [et al.] // PLoS One. - 2014. - Vol. 9. - P. e87049.
88. Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages [Text] / J. Zhou, H.K. Law, C.Y. Cheung [et al.] // J Infect Dis. - 2006. - Vol. 193, № 7. - P. 945-953.
89. Galvаn, J.M. Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia [Text] / J.M. Galvn, O. Rajas, J. Aspa // Arch Bronconeumol. - 2015. - Vol. 51, № 11. - P. 590-597.
90. Garcia-Souza, L.F. Mitochondria: biological roles in platelet physiology and pathology [Text] // L.F. Garcia-Souza, M.F. Oliveira // Int J Biochem Cell Biol. - 2014. - № 50. - Р. 156-160.
91. Gilca, R. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada [Text] / R. Gilca,
G. De Serres // Influenza Other Respi Viruses. - 2011. - Vol. 5(4). - P. 247-255.
92. Glucan microarray analysis of the hemagglutinins from modem and pandemic influenza viruses reveals different receptor specificities [Text] / J. Stevens [et al.] // J. Mol. Biol. - 2006. - Vol. 335. - P. 1143-1155.
93. Glucose-6-phosphate dehydrogenase is regulated through c-Src- mediated tyrosine phosphorylation in endothelial cells [Text] ∕ S. Pan, CJ. World, CJ. Kovacs [et al.] ∕∕ Arterioscler. Thromb. Vasco BioI. -
2009. - Vol. 29, № 6. - P. 895-901.
94. Glutathione depletion reveals impairment of antigen processing and-inhibition of cathepsin activity by nitric oxide in antigen-presenting cells [Text] ∕ G. Lemaire, O. Guittet, M.F. Vesin [et al.] ∕∕ Mol. Immunol. - 2009. - Vol. 46, № 6. - P. 1100-1108.
95. Glutathione dysregulation and the etiology and progression of human diseases [Text] ∕ N. Ballatori, S.M. Krance, S. Notenboom [et al.] ∕∕ Biol. Chem. - 2009. - Vol. 390, № 3. - P. 191-214.
96. Gutierrez-Pizarraya, A. Unexpected severity of cases of influenza B infection in patients that require hospitalization duringn the first postpandemic wave [Text] ∕ A. Gutierrez-Pizarraya, P Pi- rez-Romero, R. Alvarez [et al.] ∕∕ J. Inf. - 2012. - Vol. 65(5). - P 423-430.
97. Holoendemic Malaria Exposure Is Associated with Altered Epstein-Barr Virus-Specific CD8+ T-Cell Differentiation [Text] ∕ Pratip
K. Chattopadhyay, Kiprotich Chelimo, Paula B. Embury [et al.] ∕∕ J. Virol. - 2013. - Vol. 87, № 3. - P. 1779-1788.
98. Hospitalized patients with novel influenza A (H1N1) virus infection-California, April-May, 2009 [Text] ∕ Centers for Disease Control and Prevention ∕∕ MMWR. - 2009. - Vol. 58, № 19. - Р 536-541.
99. Human Cytomegalovirus Induces the Activity and Expression of Acetyl-Coenzyme A Carboxylase, a Fatty Acid Biosynthetic Enzyme Whose Inhibition Attenuates Viral Replication [Text] ∕ Cody M. Spencer, Xenia L. Schafer, Nathaniel J. Moorman [et al.] ∕∕ J. Virol. - 2011. - Vol. 85, № 12. - P. 5814-5824.
100. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009 [Text] ∕ World Health Organization ∕∕ Wkly Epidemiol Rec. - 2009. - Vol. 84, № 21. - P. 185-189.
101. Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009 [Text] ∕ World Health Organization ∕∕ Wkly Epidemiol Rec. - 2009. - Vol.84, № 24. - P. 237-244.
102. Human influenza viruses and CD8+ T Cell responses [Text] / EJ. Grant, S.M. Quinones-Parra, E.B. Clemens, K. Kedzierska // Current Opinion in Virology. - 2016. - Vol. 16. - P. 132-142.
103. Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension [Text] / S. Chettimada, R. Gupte, D. Rawat [et al.] // Am J Physiol Lung Cell Mol Physiol. - 2015. - № 308(3). - Р. 287-300.
104. Jose, R.J. Community-acquired pneumonia [Text] / R.J. Jose, J.N. Periselneris, J.S. Brown // Curr. Opin. Pulm. Med. - 2015. - Vol. 21, № 3 - Р 212-218.
105. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury [Text] / Y. Imai, K. Kuba, G.G. Neely [et al.] // Cell. - 2008. - Vol. 133, № 2. - P. 235-249.
106. Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand [Text] / P. Oster, J.O’ Hallahan, I. Aaberge [et al.] // Vaccine. - 2007. - Vol. 25, № 16. - P. 3075-3079.
107. Impaired NK cell antiviral cytokine response against influenza virus in small-for-gestational-age neonates [Text] / J. Li [et al.] // Cell. Mol. Immunol. - 2013. - Vol. 10 (5). - P. 437-443.
108. Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia [Text] / K. Sochorova, R. Horvath, D. Rozkova [et al.] // Blood. - 2007. - Vol. 109, № 6. - P. 2553-2556.
109. Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase [Text] / G. Cappai, M. Songini, A. Doria [et al.] // Diabetolo- gia. - 2011. - Vol. 54, № 6. - P. 1539-1542.
110. Inefficient Control of Host Gene Expression by the 2009 Pandemic H1N1 Influenza A Virus NS1 Protein [Text] / B.G. Hale, J. Steel, R.A. Medina [et al.] // J. Virol. - 2010. - Vol. 84, № 14. - P. 6909-6922.
111. Infection and Autoimmunity [Text] / Nancy Agmon Levin, Noel
R. Rose, Y. Shoenfeld. - Gardners Books, 2004. - 768 р.
112. Influenza A (H1N1)pdm09 virus suppresses RIG1 initiated innate antiviral responses in the human lung [Text] / W. Wu, W. Zhang,
J.L. Booth, J.P. Metcalf J.P. [et al.] // PLOS ONE. - 2012. - V. 7, № 11. - e49856.
113. Influenza A(H1N1)pdm09: beyond the pandemic [Text] / D. Vi- asus, A. Anton, T Pumarola, J. Carratal // Enferm. Infecc. Microbiol. Clin. - 2012. - Vol. 30, № 4. - P. 54-57.
114. Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation [Text] / M.A. Hoeve, A.A. Nash, D. Jackson [et al.] // Plos One. - 2012. - V. 7. - № 1. - e29443.
115. Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1 [Text] / D. Zamarin, A. Garcia-Sastre, X. Xiao [et al.] // PLoS Pathog. - 2005. - Vol. 1., № 1. - P. 0040-0054.
116. Influenza virus receptors in the human airway [Text] / K. Shinya, M. Ebina, S. Yamada [et al.] // Nature. - 2006. - Vol. 440. - P. 435-436.
117. Influenza infection and risk of acute pulmonary embolism [Text] / M. Van Wissen, T.T. Keller, B. Ronkes [et al.] // Thromb J. - 2007. - Oct 16, Vol. 5. - Р. 16.
118. Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009 [Text] / Centers for Disease Control and Prevention // MMWR. - 2009. - Vol. 58, № 27. - Р 749-752.
119. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells [Text] / M. Spiegel, K. Schneider, F. Weber [et al.] // J Gen Virol. - 2006. - Vol. 87, № 7. - P. 1953-1960.
120. In vitro and in vivo characterization of new swine-origin H1N1 influenza virus [Text] / Y. Itoh, K. Shinya, M. Kiso [et al.] // Nature. - 2009. - Vol. 460, № 7258. - P. 1021-1025.
121. Kash, J.C. The Role of Viral, Host, and Secondary Bacterial Factors in Influenza Pathogenesis [Text] / J.C. Kash, J.K. Taubenberger // Am. J. Pathol. - 2015. - Vol. 185, № 6. - P. 1528-1536.
122. Kauffman, KJ. Advances in flux balance analysis [Text] / KJ. Kauffman, P. Prakash, J.S. Edwards // Current Opinion in Biotechnology. - 2003. - Vol. 14, № 5. - P. 491-496.
123. Killip, M.J. Influenza virus activation of the interferon system [Text] / M.J. Killip, R.E. Randall, E. Fodor // Virus Research. - 2015. - Vol. 209. - P. 11-22.
124. Kotzamanis, K. Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection
[Text] ∕ K. Kotzamanis, A. Angulo, P. Ghazal1 ∕∕ Med. Microbiol. Immunol. - 2015. - Vol. 204, № 3. - P. 395-407.
125. Kuiken T. Pathology of human influenza revisited ∕ T. Kuiken, J. Taubenberger ∕∕ Vaccine. - 2008. - Vol. 26. - P. 59-66.
126. Lacoma, A. Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores [Text] ∕ A. Lacoma, A. Bas, P. Tudela [et al.] ∕∕ Enferm. Infecc. Microbiol. Clin. - 2014. - Vol. 32, № 3. - P. 140-146.
127. Lai, C. Cytokines Network and Influenza Virus Infection [Text] ∕ C. Lai, X. Wang, P. Yang ∕∕ Clin. Microbial. - 2014. - Vol. 3 (147). - dok10.4172∕2327-5073.1000147.
128. Levinson, W. Review of Medical Microbiology and Immunology [Text] ∕ W. Levinson. - McGraw-Hill, 2010. - 640 p.
129. Liderot, K. Secondary bacterial infections in patients with seasonal influenza A and pandemic H1N1 [Text] ∕ K. Liderot, M. Ahl, V. Ozenci ∕∕ Biomed Res Int. - 2013. - Vol. 6. - P. 1-6.
130. Littleton, S.W Impact of obesity on respiratory function [Text] ∕
S.W. Littleton ∕∕ Respirology. - 2012. - Vol. 17, № 1. - P. 43-49.
131. Longo, D.L. Community-acquired pneumonia [Text] ∕ D.L. Longo ∕∕ N. Engl. J. Med. - 2014. - Vol. 371. - P. 1619-1628.
132. Manchini, G. Immunochemical quantitation of antigens by single radial diffusion [Text] ∕ G. Manchini, A.O. Carbonaro, J.F. Haremans ∕∕ Immunochemistry. - 1965. - Vol. 2, № 3. - P. 235-255.
133. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites [Text] ∕ S. Mauerer-Stroh, J. Ma, R. Tze Chuen Lee [et al.] ∕∕ Biology Direct. - 2009. - Vol. 4, № 5. - P. 1-9.
134. Marti, C. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis [Text] ∕ C. Marti, N. Garin, O. Grosgurin [et al.] ∕∕ Crit. Care. - 2012. - Vol. 27, № 16. - P. 141.
135. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes [Text] ∕ Gannage M., Dormann D., R. Albrecht [et al.] ∕∕ Cell. Host. Microbe. - 2009. - Vol. 6. - P. 367-380.
136. Membrane Accumulation of Influenza A Virus Hemagglutinin Triggers Nuclear Export of the Viral Genome via Protein Kinase C- mediated Activation of ERK Signaling [Text] ∕ H. Marjuki, M.I. Alam,
C. Ehrhardt [et al.] // J. Biol. Chem. - 2006. - Vol. 281, № 24. - P. 16707-16715.
137. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms [Text] / K.K. McKinstry [et al.] // J. Clin. Invest. - 2012. - Vol. 122. - P. 2847-2856.
138. Min J.-Y. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2,,5,-oligo(A) synthetase [Text] / J.-Y. Min, R.M. Krug // Proc Natl Acad Sci USA. - 2006. - Vol. 103, № 18. - P. 7100-7105.
139. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV [Text] / T Sheahan, T.E. Morrison,W. Funkhouser [et al.] // PLoS Pathog. - 2008. - Vol. 4, № 12. - P. e1000240.
140. Nelson, M.I. Reverse zoonosis of influenza to swine: new perspectives on the human-animal interface [Text] / M.I. Nelson, A.L Vincent. // Trends Microbiol. - 2015. - 23 (3). - P. 142-53.
141. Neuraminidase and hemagglutinin matching patterns of a nighly pathogenic avian and two pandemic H1N1 influenza a viruses [Text] / Y. Zhang [et al.] // PLoS One. - 2010. - № 5(2). - P. 9167.
142. New horizon of mucosal immunity and vaccines [Text] / I. Takahashi, T. Nochi, Y. Yuri // Current opinion in immunologt. - 2009. - Vol. 21. - P. 352-358.
143. New influenza A (H1N1) 2009 in Singapore: the first ten adult imported cases [Text] / M. Liang, D.C. Lye, M.I. Chen [et al.] // Singapore Med J. - 2009. -Vol. 50, № 6. - P. 581-583.
144. Novel pandemic influenza A (H1N1) virus infection modulates apoptotic pathways that impact its replication in A549 cells [Text] / X. Wang [et al.] // Microbes Infect. - 2014. - Vol. 16 (3). - P. 178-186.
145. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A (H1N1) virus and severe clinical outcome, Norway 2009-2010 [Text] / A. Kilander [et al.] // Euro Surveill. -
2010. - Vol. 15, № 9.
146. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009 [Text] / Centers for Disease Control and Prevention (CDC) // MMWR. - 2009. - Vol. 58, № 17. - Р. 467-470.
147. Pandemic H1N1 Influenza. Pathology and Pathogenesis of 100 Fatal Cases in the United States [Text] / WJ. Shieh [et al.] //
AJ. Pathol. - 2010 - Vol. 177. - P. 166-175.
148. Pandemic H1N1 Chronology, August 2009, (Электронный ресурс) - Режимдоступа: URL: http://www.wpro.who.int/NR/rdon- lyres/ 18DB2FA5-5BE0-422B-B0FD-826 C5DD1 D7BD/0/Pan- demicH1N1_ Chronology_Aug09.pdf.
149. Pandemic (H1N1) 2009, Pan American Health Organization, 2009, (Электронный ресурс) - Режим доступа: URL: http://new.paho. org/hq/images/atlas/en/atlas.html.
150. Pathology and virology findings in cases of fatal influenza A H1N1 virus infection in 2009-2010 / A. Bal, V. Suri, B. Mishra [et al.] // Histopathology. - 2012. - Vol. 60. - P. 326-335.
151. Pathogenesis of influenza-induced acute respiratory distress syndrome [Text] / K.R. Short, E.J. Kroeze, R.A. Fouchier [et al.] // Lancet Infect Dis. - 2014. - Vol. 14(1). - P. 57-69.
152. PB1-F2 influenza a virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments [Text] / C. Chevalier, A. Al Bazzal, J. Vidic [et al.] // J. Biol. Chem. - 2010. - Vol. 2815, № 2. - P. 13233-13243.
153. Replication and pathogenesis of the pandemic (H1N1) 2009 influenza virus in mammalian models [Text] / D. Kwon, K. Shin, S. Kim [et al.] // J. Microbiol. - 2010. - V. 48. - P. 657-662.
154. Peteranderl, C. Human influenza virus infections [Text] / C. Pe- teranderl, S. Herold, C. Schmoldt // Seminars in Respiratory and Critical Care Medicine. - 2016. - Vol. 37, № 4. - P. 487-500.
155. Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection [Text] / Y.C.F. Su, J. Bahl, U. Joseph [et al.] // Nature Communications. - 2015. - Vol. 6. - P. 7952.
156. Pliyev, B.K. Extracellular NAD(+) inhibits human neutrophil apoptosis [Text] / B.K. Pliyev, A.V. Ivanova, V.G. Savchenko // Apoptosis. - 2014. -Vol. 19, № 4. - P. 581-593.
157. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico [Text] / R. Perez-Padilla, D. de la Rosa-Zamboni, S. Ponce de Leon [et al.] // N Engl J Med. - 2009.-Vol. 361, № 7. - P. 680-689.
158. Preparing for the second wave: lessons from current outbreaks, 28 august 2009, WHO Pandemic (H1N1) briefing note 09,(Электронныйресурс) - Режимдоступа:URL:http://www.who.
int∕csr∕disease∕swineflu∕notes∕h1n1-second-wave-20090828∕ en∕index.html.
159. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [Text] ∕ A.E. Fiore, D.K. Shay, K. Broder [et al.] ∕∕ MMWR. - 2008. - Vol. 57, № RR-7. - Р. 1-60.
160. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells [Text] ∕ A. Crawford, M. Macleod, T Schumacher [et al.] ∕∕ J Immunol. - 2006. - Vol. 176, № 6. - Р. 3498-3506.
161. Public Health Agency of Canada, weekly reports, 2008-2009 (week 34), (Электронный ресурс) - Режим доступа: URL: http√∕ www.phac-aspc.gc.ca∕fluwatch∕08-09∕w34-09∕index-eng. php.
162. Public Health Agency of Canada, weekly reports, 2009-2010 (week48), (Электронныйресурс) - Режимдоступа: URLιhttpι∕∕www. phacaspc.gc.ca∕fluwatch∕09-10∕w48-09∕index-eng.php.
163. Raman, K. Flux balance analysis of biological systems: applications and challenges [Text] ∕ K. Raman, N. Chandra ∕∕ Briefings in Bioinformatics. - 2009. - Vol. 10, № 4. - P. 435-449.
164. Rello, J. Clinical review: primary influenza viral pneumonia [Text] ∕ J. Rello, A. Pop-Vicas ∕∕ Crit Care. - 2009. - № 13(6). - P. 235
165. Resperatory disease in adults during pandemic (H1N1) 2009 outbreak, Argentina [Text] ∕ Zala C. [et al.] ∕∕ Emerg. Infect. Dis. - 2009. - Vol. 15, № 12. - P. 2060-2061.
166. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine [Text] ∕ H.W. Kim, J.G. Canchola, C.D. Brandt [et al.] ∕∕ Am. J. Epidemiol. - 2009. - Vol. 89, № 4. - P. 422-434.
167. Role for innate IFNs in determining respiratory syncytial virus immunopathology [Text] ∕ T.R. Johnson, S.E. Mertz, N. Gitiban [et al.] ∕∕ J. Immunol. - 2005. - Vol. 174, № 11. - P. 7234-7241.
168. Role of human Toll-like receptors in naturally occurring influenza infections ∕ N. Lee, C.K. Wong, D.S. Hui [et al.] ∕∕ Influenza other Respir. viruses. - 2013. - V. 7. - № 5. - P. 666-675.
169. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract [Text] ∕ K.B. Renegar, P.A. Small,
L. G. Boykins [et al.] ∕∕ J. Immunol. - 2004. - Vol. 173, № 12. - P. 1978-1986.
170. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice [Text] /
L. Qi [et al.] // J. Virol. - 2009. - Vol. 83, № 8. - P. 3754-3761.
171. Rozenbaum, M.H. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults: a meta-analysis [Text] /
M. H. Rozenbaum, P. Pechlivanoglou, T.S. van der Werf // Eur. J. Clin. Microb. Infect. Dis. - 2013. - Р. 305-316.
172. Sant, AJ. Revealing the role of CD4(+) T cells in viral immunity [Text] / AJ. Sant, A. McMichael // J. Exp. Med. - 2012. - Vol. 209. - P. 1391-1395.
173. Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study [Text] / A. Bjarnason, G. Thorleifsdottir, A. Lоve [et al.] // PLoS One. - 2012. - Vol. 7(10). - Р. e46816.
174. Stanton, R.C. Glucose-6-Phosphate Dehydrogenase, NADPH, and Cell Survival [Text] / R.C. Stanton // IUBMB Life. - 2012. - Vol. 64, № 5. - P. 362-369.
175. Structure of NADP(+)-dependent glutamate dehydrogenase from Escherichia coli-refl ections on the basis of coenzyme specifi city in the family of glutamate dehydrogenases [Text] / M. ASharkey, T. FOliveira, P.C. Engel [et al.] // FEBS J. - 2013. - № 280(18). - Р 4681-4692.
176. Substantial Morbidity and Mortality Associated with Pandemic A/H1N1 Influenza in Mexico, Winter 2013-2014: Gradual Age Shift and Severity [Text] / J. Dаvila, G. Chowell, V.H. Borja-Aburto [et al.] // PLoS Curr. - 2014. - № 6. - P. 1-14.
177. Summary of situation of Pandemic (H1N1) 2009, (Электронный ресурс) - Режим доступа: URL: http://www. searo.who. int/EN/ Section 10/Section2562.htm.
178. Swine-origin influenza A (H1N1) virus infections in a school - New York City, April 2009 [Text] / Centers for Disease Control and Prevention // MMWR. - 2009. - Vol. 58, № 17. - Р. 470-472.
179. Synthesis and anti-influenza a virus activity of 6'-amino-6'- deoxy-glucoglycerolipids analogs [Text] / L. Ren, J. Zhang, H. Ma [et al.] // Marine Drugs. - 2016. - Vol. 14, № 6. - P. 116.
180. The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese [Text] /
M.W. Ng, G. Zhou, W.P. Chong [et al.] // BMC Infect Dis. - 2007 - Vol. 7. - P. 50.
181. The fate of influenza A virus infection of human macrophages and dendritic cells / K.R. Short, A.G. Brooks, P.C. Reading [et al.] // J. General Virology. - 2012. - V. 93. - P. 2315-2325.
182. The Influenza virus resource at the National Center for Biotechnology Information [Text] / Y. Bao, P. Bolotov, D. Dernovoy [et al.] // J. of Virology. - 2008. - Vol. 82, № 2. - P. 596-601.
183. The state of specific humoral immunity in the system «mother- newborn» in women who suffered influenza A(H3N2) in different trimesters of pregnancy [Text] / М.Т. Lutsenko, I.N. Gorikov, BA. Rabinovich [et al.] // The 9th Sino-Russia Forum of Biomedical and Pharma-ceutical Forum. Harbin, China, 2012. - P. 280-281
184. Torres, A. Biomarkers and community-acquired pneumonia: tailoring management with biological data [Text] / A. Torres, P. Ramirez, B. Montull // Semin. Respir. Crit. Care Med. - 2012. - Vol. 33, № 3. - P. 266-271.
185. Torres, A. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review [Text] / A. Torres, F. Blasi, W.E. Peetermans // Eur. J. Clin. Microbiol. Infect. Dis. - 2014. - Vol. 33. - P. 1065-1079.
186. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001 [Text] / C. Rizzo, A. Bella, C. Viboud [et al.] // Emerg. Infect. Dis. - 2007. - Vol. 13, № 5. - P. 694-699.
187. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells [Text] / G. Stary, C. Bangert, M. Tauber [et al.] // J Exp Med. - 2007. - Vol. 204, № 6. - P. 1441-1451.
188. Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009 [Text] / Centers for Disease Control and Prevention // MMWR (Morb Mortal Wkly Rep). - 2009. - Vol. 58, № 16. - Р. 433-435.
189. Van der Werf, S. Influenza - the need to stay ahead of the virus [Text] / S. Van der Werf, D. Levy-Bruhl // Eurosurveillance. - 2015. - Vol. 20, № 5. - P. 1-4.
190. Wang, Z. Avian influenza viruses, inflammation, and CD8+ T cell immunity [Text] / Z. Wang, L. Loh, L. Kedzierski // Frontiers in Immunology. - 2016. - Vol. 7. - P 60.
191. Weekly Epidemiological Monitor, November 2009, 2(44). (Электронныйресурс - Режимдоступа: http://www.emro. who.int/ csr/h1n1/pdf/epi_monitor_44_09.pdf (дата обращения: 18.12.2009 г.).
192. WHO. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness [Электронный ресурс] // Sept. 2015. - Режим доступа: http://www.who.int/influenza/vaccines/virus/201509_zoonotic_vac- cinevirusupdate.pdf?ua=1.
193. WHO. 2009. Pandemic (H1N1) 2009-update 64. / World Health Organization. Situation Update, 8 January 2014. http://www. who.int/csr/don/2010_05_28/en/index.html.
Еще по теме СПИСОК ЛИТЕРАТУРЫ:
- СПИСОК ЛИТЕРАТУРЫ
- СПИСОК ЛИТЕРАТУРЫ
- Список литературы:
- Список литературы
- СПИСОК ЛИТЕРАТУРЫ
- СПИСОК ЛИТЕРАТУРЫ
- СПИСОК ЛИТЕРАТУРЫ
- Список литературы
- СПИСОК ЛИТЕРАТУРЫ:
- Список литературы
- Список литературы
- СПИСОК ЛИТЕРАТУРЫ
- СПИСОК ЛИТЕРАТУРЫ
- СПИСОК ЛИТЕРАТУРЫ
- Список литературы
- СПИСОК ЛИТЕРАТУРЫ
- Список литературы
- Список литературы
- Список литературы
- Список литературы